REVB · Revelation Biosciences, Inc. · Proposed Sales
$3.71
+0.02 (+0.54%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not anticipate that our current cash and cash equivalents balance will be sufficient to sustain operations within one year after the date that our unaudited financial statements for September 30, 2026 were issued, which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 5, 2026
Market Cap
$2.52M
Shares
683,442
Volume · Nov 20
1858
Avg daily vol (23 sessions)
20.32K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Key facts
CIK
1810560
CUSIP
76135L887
13F (30d)
16 filings
14 filers
Visit website
Investor relations